Risk factors of hyperparathyroidism in advanced stages of chronic kidney disease by El Kossi M, Rana A, El Nahas M

Get full text

UK Kidney Association clinical practice guideline: sodium-glucose co-transporter-2 (sglt-2) inhibition in adults with kidney disease 2023 update by Roddick, AJ, Wonnacott, A, Webb, D, Watt, A, Watson, MA, Staplin, N, Riding, A, Lioudaki, E, Kuverji, A, El Kossi, M, Holmes, P, Holloway, M, Fraser, D, Carvalho, C, Burton, JO, Bhandari, S, Herrington, WG, Frankel, AH